| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP Clinical Reg Affairs | VP Clinical Reg. Affairs
1 company
Thompson Jaye is a VP Clinical Reg Affairs at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $6.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 1,000 | $12.91 | $12,910.00 | +0.4% | |
| Aug 12, 2024 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 800 | $13.85 | $11,080.00 | +0.3% | |
| Aug 2, 2024 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 1,000 | $15.15 | $15,150.00 | +0.4% | |
| Jul 18, 2024 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 1,000 | $16.00 | $16,000.00 | +0.4% | |
| Oct 27, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 500 | $8.57 | $4,285.00 | +0.2% | |
| Sep 26, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 600 | $8.71 | $5,226.00 | +0.2% | |
| Jul 13, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $9.49 | $2,372.50 | - | |
| Apr 28, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $11.22 | $2,805.00 | - | |
| Apr 11, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 1,000 | $11.87 | $11,870.00 | +0.4% | |
| Mar 15, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $12.71 | $3,177.50 | - |